Bayer Latest to Join Protein Degrader Space with Arvinas Collaboration
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 6 (Table of Contents)
Published: 14 Jun-2019
DOI: 10.3833/pdr.v2019.i6.2432 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Bayer has agreed to collaborate with Arvinas on the targeted protein degradation of disease-causing proteins to develop therapeutics for a range of cardiovascular, oncological, and gynaecological diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS